Delivery Order SPE2DB22D3019-SPE2DB24FK3PF
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, valued at $1,465.68, for the supply of the pharmaceutical product ENVARSUS XR 1 MG TABLET 30S. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $1,615.33 to supply ENVARSUS XR 4 MG TABLET 100S. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,216.11 contract is for the provision of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product, with a period of performance through April 22, 2024. This delivery order is a task order under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to...
- The Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of ENVARSUS XR 1 MG TABLET 100S. The contract has a completion date of March 8, 2024 and a potential value of $1,216.11. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, a firm fixed price delivery order contract valued at $1,615.33 to provide ENVARSUS XR 4 MG TABLET 100S. This award is under Amerisourcebergen's existing indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENVARSUS XR 4 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $6,847.80 and an ultimate completion date of February 27, 2025. This is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any specific business designation....
- This is a firm-fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $2,148.10 and a period of performance through August 1, 2025. The contract is not set aside and was awarded on July 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order valued at $1,465.68 by the Defense Logistics Agency (DLA) to provide ENVARSUS XR 1 MG TABLET 30S through March 6, 2024. This award is part of Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) with DLA Troop Support Medical, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- This is a $1,718.48 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product, with a period of performance through May 5, 2025. The award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,711.95 contract is for the supply of ENVARSUS XR 4 MG TABLET 100S, a medication. The contract has an ultimate completion date of July 14, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB24FK3PFDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of ENVARSUS XR 0.75 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $5,518.20 and an ultimate completion date of August 2, 2024. This award is under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's medical treatment programs and facilities worldwide. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 7/12/24 |